Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory
We came across a bullish thesis on Sarepta Therapeutics, Inc. (SRPT) on Substack by Two Natural Capital. In this article, we will summarize the bulls’ thesis on SRPT.
Posts Tagged ‘NASDAQ:SRPT’
12 High Growth Large Cap Stocks to Buy Now
BlackRock highlighted that its portfolio managers are broadly optimistic about US equities.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q3 2024 Earnings Call Transcript
Operator: Good day and welcome to the Sarepta Therapeutics Third Quarter 2024 Financial Results Conference Call.
8 Unstoppable Stocks That Could Make You Richer
In the current climate of extreme market volatility, finding safe and stable investments is challenging.
10 Most Promising Biotech Stocks According to Hedge Funds
Biotechnology stocks are known for their high risk, making them some of the most volatile in the market.
7 Best Revenue Growth Stocks to Buy According to Analysts
The Fed recently cut the funds rate by 50 basis points which has been considered a bold move by some analysts while others and most of the market have welcomed it with open arms...
10 Largest Biotech Hedge Funds and Their Top Stock Picks
The ability to successfully make money through investment requires deep thinking and analysis.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q2 2024 Earnings Call Transcript
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q2 2024 Earnings Call Transcript August 7, 2024Sarepta Therapeutics, Inc. beats earnings expectations.
Sarepta Therapeutics (NASDAQ:SRPT) A Bull Case Theory
We came across a bullish thesis on Sarepta Therapeutics (SRPT) on X (formerly Twittter) by user quantumup. In this article we will summarize the bulls' thesis on SRPT.
Is Sarepta Therapeutics, Inc. (NASDAQ:SRPT) A Good Fast Growth Stock To Buy?
We recently compiled the list of the 10 Best Fast Growth Stocks To Buy according to the hedge funds using the latest sentiment data.
10 Best Fast Growth Stocks To Buy Now
Growth stocks are those that are either growing their revenue in mid to high double or triple digit percentages or those who trade at significantly higher prices when compared...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript
Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.37, expectations were $-0.11. Sarepta Therapeutics, Inc.
5 Unstoppable Stocks That Will Make You Richer
In this article, we discuss the 5 unstoppable stocks that will make you richer.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Billionaire Ken Fisher and Corporate Insiders Are Buying These 10 Stocks
In this article, we will take a detailed look at Billionaire Ken Fisher and Corporate Insiders Are Buying These 10 Stocks.
Billionaire Ray Dalio and Insiders Love These 10 Stocks
In this article, we will take a detailed look at Billionaire Ray Dalio and Insiders Love These 10 Stocks. For a quick overview of such stocks, read our article Billionaire Ray...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2023 Earnings Call Transcript
Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.47, expectations were $-0.03. Sarepta Therapeutics, Inc.
5 Best Small-Cap Growth Stocks to Invest In
In this piece, we will take a look at the five best small-cap growth stocks to invest in.
Growth Stock Portfolio: 15 Companies with At Least 30% Annual Growth Rates
In this article, we will take a look at the 15 stocks with at least 30% annual growth rates to consider for a growth stock portfolio.
5 Best Mid-Cap Growth Stocks To Buy Now
This article presents an overview of the 5 Best Mid-Cap Growth Stocks To Buy Now.
15 Best Fast Growth Stocks to Buy Now
In this article, we will take a look at the 15 best fast growth stocks to buy now.
13 High Growth Healthcare Stocks to Buy
In this article, we will take a look at 13 high growth healthcare stocks to buy.
5 Stocks Insiders and Billionaires Are Crazy About
This article presents an overview of the 5 Stocks Insiders and Billionaires Are Crazy About. For a detailed overview of such stocks, read our article, 11 Stocks Insiders ...
10 Beaten Down Stocks Billionaires Are Crazy About
In this article, we will take a look at the 10 beaten down stocks billionaires are crazy about.
5 Best Upside Stocks To Buy Now
In this piece, we will take a look at the five best upside stocks to buy right now.
13 Stocks Insiders are Buying Now
With the end of 2023 now in sight, many can say with confidence that the much-dreaded recession everyone was talking about will not realize this year.
Here’s What Bronte Capital Calls “Sarepta Risk” in the Context of Sarepta Therapeutics (SRPT)
Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q3 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Sarepta Therapeutics Third Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode.
Analysts on Wall Street Lower Ratings for These 5 Stocks
In this article, we discuss the 5 stocks receiving downgrades from analysts.
5 Best Long-term Stocks To Buy For High Returns
In this piece, we will take a look at the five best long term stocks to buy for high returns.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q2 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Sarepta Therapeutics Second Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode.
10 Oversold Biotech Stocks to Buy
In this article, we will take a look at the 10 oversold biotech stocks to buy.
5 Best Economic Recovery Stocks to Buy
In this piece, we will take a look at the five best economic recovery stocks to buy.
5 Healthcare Stocks Billionaires Are Loading Up On
In this article, we discuss 5 best healthcare stocks billionaires are loading up on.
15 Best Healthcare Stocks To Buy Now
In the midst of uncertain economic conditions globally, the healthcare sector has displayed a notable degree of resilience.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Sarepta Therapeutics First Quarter 2023 Earnings Call. At this time all participants are in a listen-only mode.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2022 Earnings Call Transcript
Operator: Good afternoon and welcome to the Sarepta Therapeutics Fourth Quarter and Full Year 2022 Earnings Call. As a reminder, today's conference call is being recorded.
5 Best Healthcare Stocks For Recession
McKesson Corporation (NYSE:MCK) is one of the most notable healthcare companies in the US.
5 Best Genomics Stocks To Buy Now
Agilent Technologies, Inc. (NYSE:A) provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Top 10 Stock Picks of Eli Casdin’s Casdin Capital
In this article, we discuss the top 10 stock picks of Eli Casdin's Casdin Capital.
10 Best Pharma Stocks To Buy Now
With a compound annual growth rate (CAGR) of 9.1%, the global pharmaceuticals industry is projected to expand to $1587.1 billion in 2022 from $1454.7 billion in 2021.
5 Healthcare Stocks to Buy Today According to Steven Cohen’s Point72 Asset Management
In this piece we will take a look at the top five healthcare stocks to buy today according to Steven Cohen's Point72 Asset Management. If you want to learn about Mr.
Hedge Funds Are Souring On Sarepta Therapeutics Inc (SRPT)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
5 Biotech and Pharma Stocks to Buy According to Billionaire Steve Cohen
In this piece, we will take a look at the 5 biotech and pharma stocks to buy according to billionaire Steve Cohen. If you want to check out more stocks and learn about Mr.
Hedge Fund and Insider Trading News: Dalton Investments, Balyasny Asset Management, Livermore Partners, IsZo Capital Management, Sarepta Therapeutics Inc (SRPT), Tabula Rasa HealthCare Inc (TRHC), and More
Dalton Investments, a $3.4 billion U.S. investment firm, says it’s still on the fence over whether to support Shinsei Bank Ltd.’s management or SBI Holdings Inc.
5 Stocks Cathie Wood is Selling
In this article, we discuss Tesla and the 4 other stocks that Cathie Wood is selling.
11 Best Genomic Stocks to Buy Now
In this article, we will take a look at the 11 best genomic stocks to buy now.
Should I Buy Sarepta Therapeutics Inc (SRPT)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Cathie Wood is Getting Rid of These 10 Stocks
In this article, we discuss the 10 stocks Cathie Wood is getting rid of.
Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
